Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Marfan Syndrome | 24 | 2023 | 237 | 4.460 |
Why?
|
Atenolol | 12 | 2020 | 99 | 3.090 |
Why?
|
Losartan | 12 | 2020 | 263 | 2.770 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 10 | 2020 | 429 | 2.330 |
Why?
|
Aorta | 11 | 2023 | 2046 | 1.500 |
Why?
|
Adrenergic beta-Antagonists | 6 | 2022 | 1244 | 1.300 |
Why?
|
Connective Tissue Diseases | 4 | 2017 | 285 | 1.230 |
Why?
|
Aortic Diseases | 8 | 2024 | 742 | 1.160 |
Why?
|
Adrenergic beta-1 Receptor Antagonists | 4 | 2020 | 30 | 0.910 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2015 | 709 | 0.890 |
Why?
|
Aortic Aneurysm | 4 | 2015 | 649 | 0.810 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2021 | 48 | 0.720 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2021 | 313 | 0.670 |
Why?
|
Chromosome Deletion | 2 | 2023 | 1390 | 0.560 |
Why?
|
Vertebral Artery | 2 | 2014 | 186 | 0.460 |
Why?
|
Skin Diseases, Genetic | 1 | 2014 | 49 | 0.450 |
Why?
|
Noonan Syndrome | 2 | 2014 | 122 | 0.430 |
Why?
|
Heart Valve Diseases | 3 | 2023 | 1033 | 0.430 |
Why?
|
Aortic Valve | 7 | 2023 | 1968 | 0.390 |
Why?
|
Infant | 32 | 2024 | 36497 | 0.370 |
Why?
|
Aneurysm | 1 | 2014 | 338 | 0.370 |
Why?
|
Arteries | 2 | 2023 | 1126 | 0.360 |
Why?
|
Child, Preschool | 36 | 2024 | 42623 | 0.350 |
Why?
|
Loeys-Dietz Syndrome | 3 | 2023 | 40 | 0.350 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2742 | 0.330 |
Why?
|
Vascular Malformations | 1 | 2014 | 469 | 0.310 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2258 | 0.310 |
Why?
|
Dilatation, Pathologic | 4 | 2020 | 528 | 0.290 |
Why?
|
Joint Instability | 1 | 2014 | 802 | 0.280 |
Why?
|
Echocardiography | 9 | 2023 | 5043 | 0.270 |
Why?
|
Child | 31 | 2024 | 80863 | 0.260 |
Why?
|
Heart Septal Defects, Ventricular | 3 | 2011 | 477 | 0.220 |
Why?
|
Aortic Valve Insufficiency | 2 | 2020 | 577 | 0.220 |
Why?
|
Heart Septal Defects, Atrial | 3 | 2011 | 452 | 0.220 |
Why?
|
Chromosome Disorders | 4 | 2023 | 499 | 0.220 |
Why?
|
Magnetic Resonance Angiography | 3 | 2015 | 1434 | 0.210 |
Why?
|
Ectopia Lentis | 1 | 2022 | 20 | 0.200 |
Why?
|
Adolescent | 24 | 2024 | 89168 | 0.190 |
Why?
|
Collagen Type V | 1 | 2021 | 16 | 0.190 |
Why?
|
Transcription Factors | 1 | 2021 | 12174 | 0.180 |
Why?
|
Mitral Valve Insufficiency | 4 | 2018 | 1414 | 0.180 |
Why?
|
Collagen Type III | 1 | 2021 | 92 | 0.180 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 2020 | 52 | 0.180 |
Why?
|
Dwarfism | 1 | 2021 | 137 | 0.170 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8051 | 0.170 |
Why?
|
Aortic Coarctation | 2 | 2015 | 278 | 0.170 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2017 | 1092 | 0.160 |
Why?
|
Female | 45 | 2023 | 396943 | 0.160 |
Why?
|
Male | 41 | 2023 | 364781 | 0.160 |
Why?
|
Phenotype | 7 | 2023 | 16712 | 0.150 |
Why?
|
Young Adult | 12 | 2020 | 60045 | 0.150 |
Why?
|
Humans | 68 | 2024 | 768451 | 0.150 |
Why?
|
Thinness | 1 | 2021 | 483 | 0.140 |
Why?
|
Aorta, Thoracic | 2 | 2017 | 1107 | 0.140 |
Why?
|
Retrospective Studies | 14 | 2020 | 81834 | 0.140 |
Why?
|
Microcephaly | 1 | 2021 | 426 | 0.140 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4780 | 0.130 |
Why?
|
Adult | 22 | 2023 | 223542 | 0.130 |
Why?
|
Infant, Newborn | 16 | 2023 | 26395 | 0.130 |
Why?
|
Aortic Valve Stenosis | 3 | 2020 | 2032 | 0.130 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2018 | 578 | 0.130 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2015 | 38 | 0.120 |
Why?
|
Face | 1 | 2021 | 1031 | 0.120 |
Why?
|
Hypertension, Pulmonary | 2 | 2021 | 1605 | 0.120 |
Why?
|
Heart Defects, Congenital | 5 | 2018 | 4713 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2022 | 1066 | 0.110 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2015 | 216 | 0.110 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2018 | 614 | 0.100 |
Why?
|
Intestinal Polyposis | 1 | 2012 | 42 | 0.100 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 2022 | 1518 | 0.100 |
Why?
|
Antihypertensive Agents | 2 | 2018 | 2028 | 0.100 |
Why?
|
Gestational Age | 1 | 2021 | 3615 | 0.100 |
Why?
|
Smad4 Protein | 1 | 2012 | 193 | 0.100 |
Why?
|
Echocardiography, Doppler | 2 | 2012 | 899 | 0.090 |
Why?
|
Early Termination of Clinical Trials | 1 | 2011 | 70 | 0.090 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2012 | 142 | 0.090 |
Why?
|
Linear Models | 3 | 2018 | 5880 | 0.090 |
Why?
|
Heart Septal Defects | 1 | 2011 | 191 | 0.090 |
Why?
|
Pilot Projects | 3 | 2020 | 8730 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 3 | 2011 | 3682 | 0.090 |
Why?
|
Heart | 1 | 2023 | 4451 | 0.090 |
Why?
|
Patient Compliance | 1 | 2020 | 2696 | 0.090 |
Why?
|
Pulmonary Artery | 2 | 2013 | 1949 | 0.080 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1364 | 0.080 |
Why?
|
Mitral Valve | 1 | 2018 | 1473 | 0.080 |
Why?
|
Abnormalities, Multiple | 6 | 2011 | 1424 | 0.080 |
Why?
|
Follow-Up Studies | 8 | 2020 | 39430 | 0.080 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 1509 | 0.080 |
Why?
|
Treatment Outcome | 10 | 2018 | 65409 | 0.080 |
Why?
|
Enalapril | 1 | 2011 | 316 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10358 | 0.080 |
Why?
|
Heart Ventricles | 2 | 2018 | 3839 | 0.080 |
Why?
|
Severity of Illness Index | 6 | 2018 | 15965 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4266 | 0.080 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 15638 | 0.070 |
Why?
|
Lymphangioma | 1 | 1988 | 61 | 0.070 |
Why?
|
Genotype | 3 | 2022 | 13047 | 0.070 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 1987 | 38 | 0.070 |
Why?
|
Down Syndrome | 2 | 2018 | 914 | 0.070 |
Why?
|
Genitalia, Female | 1 | 1988 | 146 | 0.070 |
Why?
|
American Heart Association | 2 | 2024 | 1049 | 0.070 |
Why?
|
Hypoplastic Left Heart Syndrome | 2 | 2011 | 595 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1760 | 0.070 |
Why?
|
Turner Syndrome | 1 | 1988 | 130 | 0.070 |
Why?
|
Heart Block | 1 | 2008 | 390 | 0.070 |
Why?
|
Catheterization | 1 | 2012 | 1431 | 0.070 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 614 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20231 | 0.070 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1395 | 0.070 |
Why?
|
Umbilical Cord | 1 | 1987 | 179 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1885 | 0.060 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 1987 | 361 | 0.060 |
Why?
|
Mutation | 5 | 2022 | 30243 | 0.060 |
Why?
|
Ultrasonography, Prenatal | 3 | 2002 | 1767 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6856 | 0.060 |
Why?
|
Heart Neoplasms | 1 | 1987 | 374 | 0.060 |
Why?
|
Edema | 1 | 1988 | 766 | 0.060 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2007 | 329 | 0.060 |
Why?
|
United States | 7 | 2024 | 73121 | 0.050 |
Why?
|
Williams Syndrome | 2 | 2013 | 195 | 0.050 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2011 | 353 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2015 | 3665 | 0.050 |
Why?
|
Age Factors | 3 | 2015 | 18478 | 0.050 |
Why?
|
Chromosome Aberrations | 2 | 1999 | 1781 | 0.050 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2023 | 348 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11930 | 0.050 |
Why?
|
Carcinoma, Basal Cell | 1 | 1987 | 564 | 0.050 |
Why?
|
Hospitals, Pediatric | 1 | 2011 | 1876 | 0.050 |
Why?
|
Infant, Premature, Diseases | 1 | 2007 | 712 | 0.050 |
Why?
|
Hernia, Diaphragmatic | 1 | 2002 | 244 | 0.050 |
Why?
|
Quality of Life | 2 | 2023 | 13497 | 0.050 |
Why?
|
Dextrocardia | 1 | 2000 | 37 | 0.050 |
Why?
|
Disease Progression | 2 | 2018 | 13655 | 0.040 |
Why?
|
Cardiovascular Abnormalities | 1 | 1999 | 143 | 0.040 |
Why?
|
Cardiomegaly | 1 | 2001 | 591 | 0.040 |
Why?
|
Prognosis | 3 | 2018 | 30028 | 0.040 |
Why?
|
Fatal Outcome | 2 | 2019 | 1840 | 0.040 |
Why?
|
Dilatation | 1 | 2018 | 311 | 0.030 |
Why?
|
Research Design | 2 | 2015 | 6217 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2019 | 6091 | 0.030 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2017 | 94 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2020 | 775 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1468 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2013 | 3438 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 281 | 0.030 |
Why?
|
Prospective Studies | 7 | 2023 | 54914 | 0.030 |
Why?
|
Aneuploidy | 1 | 2018 | 572 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1221 | 0.030 |
Why?
|
Death, Sudden | 1 | 1996 | 301 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1444 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2005 | 1569 | 0.030 |
Why?
|
Middle Aged | 5 | 2023 | 223418 | 0.030 |
Why?
|
Data Collection | 1 | 2023 | 3329 | 0.030 |
Why?
|
Aortic Stenosis, Supravalvular | 1 | 2013 | 28 | 0.030 |
Why?
|
Genetic Variation | 2 | 2019 | 6610 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2533 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 1988 | 2915 | 0.030 |
Why?
|
Risk Assessment | 4 | 2018 | 24311 | 0.030 |
Why?
|
Alagille Syndrome | 1 | 2013 | 45 | 0.030 |
Why?
|
Phosphoglucomutase | 1 | 1992 | 6 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2018 | 971 | 0.030 |
Why?
|
Risk Factors | 4 | 2018 | 74915 | 0.030 |
Why?
|
Calsequestrin | 1 | 1992 | 30 | 0.030 |
Why?
|
Lung | 2 | 2002 | 10090 | 0.030 |
Why?
|
Smad3 Protein | 1 | 2012 | 166 | 0.030 |
Why?
|
Sarcoplasmic Reticulum | 1 | 1992 | 164 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 662 | 0.020 |
Why?
|
Fetal Death | 2 | 1999 | 438 | 0.020 |
Why?
|
Gene Deletion | 1 | 2019 | 2674 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 306 | 0.020 |
Why?
|
Smith-Magenis Syndrome | 1 | 2011 | 19 | 0.020 |
Why?
|
Constriction, Pathologic | 2 | 2013 | 1103 | 0.020 |
Why?
|
Stroke Volume | 2 | 2018 | 5620 | 0.020 |
Why?
|
Hemodynamics | 2 | 2013 | 4202 | 0.020 |
Why?
|
Genes, Dominant | 2 | 1998 | 856 | 0.020 |
Why?
|
Chromosome Duplication | 1 | 2011 | 76 | 0.020 |
Why?
|
Angioplasty | 1 | 2013 | 357 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2023 | 4417 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3624 | 0.020 |
Why?
|
Fetus | 3 | 2002 | 1883 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4861 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 2046 | 0.020 |
Why?
|
Survival Rate | 2 | 2018 | 12875 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 474 | 0.020 |
Why?
|
Receptors, Nicotinic | 1 | 1992 | 494 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2190 | 0.020 |
Why?
|
Carbamazepine | 1 | 1989 | 224 | 0.020 |
Why?
|
DNA | 2 | 2020 | 7213 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1503 | 0.020 |
Why?
|
Orofaciodigital Syndromes | 1 | 1987 | 21 | 0.020 |
Why?
|
Isoenzymes | 1 | 1992 | 1685 | 0.020 |
Why?
|
Pedigree | 3 | 1998 | 4545 | 0.020 |
Why?
|
Muscles | 1 | 1992 | 1582 | 0.020 |
Why?
|
Branchial Region | 1 | 1987 | 36 | 0.020 |
Why?
|
Situs Inversus | 1 | 1987 | 63 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1136 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2010 | 15880 | 0.020 |
Why?
|
Surface-Active Agents | 1 | 2007 | 152 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6537 | 0.020 |
Why?
|
Logistic Models | 2 | 2013 | 13324 | 0.020 |
Why?
|
Microphthalmos | 1 | 1987 | 58 | 0.020 |
Why?
|
Sex Distribution | 1 | 2012 | 2286 | 0.020 |
Why?
|
Reoperation | 2 | 2010 | 4342 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7451 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2826 | 0.020 |
Why?
|
Base Sequence | 3 | 2011 | 12428 | 0.020 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1989 | 341 | 0.020 |
Why?
|
Length of Stay | 2 | 2010 | 6521 | 0.020 |
Why?
|
Age Distribution | 1 | 2012 | 2881 | 0.020 |
Why?
|
Hand Deformities, Congenital | 1 | 1987 | 175 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2010 | 5371 | 0.020 |
Why?
|
Genome, Human | 1 | 2019 | 4453 | 0.020 |
Why?
|
Syndrome | 4 | 1998 | 3278 | 0.020 |
Why?
|
Twins | 1 | 1987 | 340 | 0.020 |
Why?
|
Lip | 1 | 1987 | 198 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10784 | 0.020 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2010 | 362 | 0.020 |
Why?
|
Placenta Diseases | 1 | 1987 | 199 | 0.020 |
Why?
|
Canada | 1 | 2010 | 2143 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2018 | 3629 | 0.020 |
Why?
|
Karyotyping | 1 | 1987 | 1173 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 2003 | 0.010 |
Why?
|
Abortion, Induced | 2 | 2002 | 475 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 2525 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6242 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 1996 | 2056 | 0.010 |
Why?
|
X Chromosome | 1 | 1987 | 819 | 0.010 |
Why?
|
Facial Expression | 1 | 1987 | 515 | 0.010 |
Why?
|
Phosphoproteins | 1 | 1992 | 2450 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12561 | 0.010 |
Why?
|
Growth Disorders | 1 | 1987 | 635 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4120 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1987 | 2342 | 0.010 |
Why?
|
Genetic Testing | 1 | 2015 | 3586 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2002 | 420 | 0.010 |
Why?
|
Spleen | 1 | 1987 | 2298 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4249 | 0.010 |
Why?
|
Functional Laterality | 1 | 1987 | 2268 | 0.010 |
Why?
|
Gene Expression | 1 | 1992 | 7605 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2005 | 1208 | 0.010 |
Why?
|
Myocardium | 1 | 1992 | 4788 | 0.010 |
Why?
|
Amniocentesis | 1 | 1999 | 116 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4630 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 16029 | 0.010 |
Why?
|
Pregnancy, High-Risk | 1 | 1999 | 121 | 0.010 |
Why?
|
Pregnancy | 4 | 2000 | 30179 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2011 | 3941 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9687 | 0.010 |
Why?
|
Placenta | 1 | 1987 | 1724 | 0.010 |
Why?
|
Cohort Studies | 2 | 2012 | 41797 | 0.010 |
Why?
|
Critical Care | 1 | 2010 | 2717 | 0.010 |
Why?
|
Kidney | 1 | 1993 | 7064 | 0.010 |
Why?
|
Toes | 1 | 1998 | 209 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9623 | 0.010 |
Why?
|
Prevalence | 2 | 2008 | 15880 | 0.010 |
Why?
|
Organ Size | 1 | 2002 | 2268 | 0.010 |
Why?
|
Maternal Age | 1 | 1999 | 809 | 0.010 |
Why?
|
Scalp | 1 | 1998 | 392 | 0.010 |
Why?
|
Fingers | 1 | 1998 | 511 | 0.010 |
Why?
|
Comorbidity | 1 | 2010 | 10601 | 0.010 |
Why?
|
Coronary Circulation | 1 | 1981 | 1617 | 0.010 |
Why?
|
Ventricular Outflow Obstruction | 1 | 1996 | 262 | 0.010 |
Why?
|
Neuromuscular Diseases | 1 | 1996 | 262 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 21552 | 0.010 |
Why?
|
Nephrocalcinosis | 1 | 1993 | 52 | 0.010 |
Why?
|
Chromatography | 1 | 1992 | 189 | 0.010 |
Why?
|
Hydroxyapatites | 1 | 1992 | 73 | 0.010 |
Why?
|
Calcium-Transporting ATPases | 1 | 1992 | 122 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1999 | 1274 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1992 | 525 | 0.010 |
Why?
|
Durapatite | 1 | 1992 | 166 | 0.010 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1992 | 706 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1992 | 1553 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1992 | 13452 | 0.010 |
Why?
|
Time Factors | 2 | 2010 | 40271 | 0.010 |
Why?
|
Molecular Weight | 1 | 1992 | 2173 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1734 | 0.010 |
Why?
|
Radiography | 1 | 2001 | 6995 | 0.010 |
Why?
|
Gene Library | 1 | 1992 | 1064 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1992 | 17647 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23638 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10125 | 0.010 |
Why?
|
Hemorrhage | 1 | 1981 | 3458 | 0.000 |
Why?
|
Calcium Channels | 1 | 1992 | 624 | 0.000 |
Why?
|
Heart Failure | 1 | 1992 | 11857 | 0.000 |
Why?
|
Mice | 1 | 2015 | 82045 | 0.000 |
Why?
|
RNA, Messenger | 2 | 1992 | 12813 | 0.000 |
Why?
|
Brain Diseases | 1 | 1996 | 1553 | 0.000 |
Why?
|
Cloning, Molecular | 1 | 1992 | 4175 | 0.000 |
Why?
|
Animals | 3 | 2015 | 169418 | 0.000 |
Why?
|
Rabbits | 1 | 1992 | 4786 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14728 | 0.000 |
Why?
|
Mexico | 1 | 1987 | 766 | 0.000 |
Why?
|
Kinetics | 1 | 1992 | 6348 | 0.000 |
Why?
|
Genes, Recessive | 1 | 1987 | 625 | 0.000 |
Why?
|
Protein Conformation | 1 | 1992 | 3973 | 0.000 |
Why?
|
Predictive Value of Tests | 1 | 2001 | 15460 | 0.000 |
Why?
|
Coronary Disease | 1 | 1996 | 5926 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1996 | 13026 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1981 | 11515 | 0.000 |
Why?
|
Peptide Fragments | 1 | 1992 | 5152 | 0.000 |
Why?
|
Macaca | 1 | 1981 | 417 | 0.000 |
Why?
|
Anticonvulsants | 1 | 1989 | 1923 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1989 | 6320 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1989 | 2959 | 0.000 |
Why?
|
Myocardial Revascularization | 1 | 1981 | 796 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1981 | 3122 | 0.000 |
Why?
|
Models, Biological | 1 | 1981 | 9505 | 0.000 |
Why?
|